000 01441 a2200397 4500
005 20250516104920.0
264 0 _c20131029
008 201310s 0 0 eng d
022 _a1873-2402
024 7 _a10.1016/j.biopsych.2012.07.022
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aYang, Chun
245 0 0 _aAcute increases in plasma mammalian target of rapamycin, glycogen synthase kinase-3β, and eukaryotic elongation factor 2 phosphorylation after ketamine treatment in three depressed patients.
_h[electronic resource]
260 _bBiological psychiatry
_cJun 2013
300 _ae35-6 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAdult
650 0 4 _aAntidepressive Agents
_xtherapeutic use
650 0 4 _aDepression
_xblood
650 0 4 _aEukaryotic Initiation Factor-2
_xblood
650 0 4 _aGlycogen Synthase Kinase 3
_xblood
650 0 4 _aGlycogen Synthase Kinase 3 beta
650 0 4 _aHumans
650 0 4 _aKetamine
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aPhosphorylation
_xdrug effects
650 0 4 _aSirolimus
_xblood
650 0 4 _aTime Factors
650 0 4 _aYoung Adult
700 1 _aZhou, Zhi-qiang
700 1 _aGao, Zhi-qin
700 1 _aShi, Jin-yun
700 1 _aYang, Jian-Jun
773 0 _tBiological psychiatry
_gvol. 73
_gno. 12
_gp. e35-6
856 4 0 _uhttps://doi.org/10.1016/j.biopsych.2012.07.022
_zAvailable from publisher's website
999 _c22017830
_d22017830